Veradermics, Incorporated (MANE)
NYSE
139.55
+2.89 (+2.11%)
Closed
Oct 22, 2026
Day's Range
136.43141.45
52 wk Range
32.00141.45
Financial Statements - MANE - Veradermics, Incorporated
Revenue
0
Net Income
-69.99M▼ 164.3%
EBITDA
-69.99M▼ 170.2%
Free Cash Flow
-71.62M▼ 202.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Sales | 0 | 0 | 0 |
| Cost of Goods | - | - | - |
| Gross Profit | - | - | - |
 Operating Expense | - | - | - |
| Operating Income | -71.55M | -26.38M | -17.32M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | - | - | - |
| Pre Tax Income | -69.99M | -26.48M | -16.49M |
| Income Tax | 0 | 0 | 0 |
| Net Income | -69.99M | -26.48M | -16.49M |
| EPS Basic | -2.376851 | -1.371538 | -1.51 |
| EPS Diluted | -2.376851 | -1.371538 | -1.51 |
| Basic Shares Outstanding | 35.07M | 19.90M | 13.80M |
| Diluted Shares Outstanding | 35.07M | 19.90M | 13.80M |
| Ebit | -69.99M | -25.90M | -16.45M |
| Ebitda | -69.99M | -25.90M | -16.45M |
| Net Income Continuous Operations | -69.99M | -26.48M | -16.49M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
